Future work will determine the mechanisms of epigenetic regulation in AD involved in antipsychotics along with expanding the investigation of side-effects beyond motor side effects that may provide greater evidence for the adjunct HDAC inhibitor treatment as a viable option for AD patients treated with antipsychotics to reduce side-effects and increase efficacy of these important medications. The gene discussed is HDAC9; the disease is Alzheimer disease.